Jun Ho Yi

Impact of <i>KRAS</i> Mutations on Clinical Outcomes in Pancreatic Cancer Patients Treated with First-line Gemcitabine-Based Chemotherapy

Seung Tae Kim, Do Hyoung Lim, Kee‐Taek Jang et al. · Molecular Cancer Therapeutics · 2011 · 145 citations

Medicine, Oncology, Pathology +15

Folate-decorated maleilated pullulan–doxorubicin conjugate for active tumor-targeted drug delivery

Haitao Zhang, Fei Li, Jun Ho Yi et al. · European Journal of Pharmaceutical Sciences · 2011 · 108 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +14

Implications of Bone-Only Metastases in Breast Cancer: Favorable Preference with Excellent Outcomes of Hormone Receptor Positive Breast Cancer

Su Jin Lee, Silvia Park, Hee Kyung Ahn et al. · Cancer Research and Treatment · 2011 · 102 citations · Full text

Medicine, Oncology, Surgery +17

Multicenter retrospective analysis of the clinicopathologic features of monomorphic epitheliotropic intestinal T-cell lymphoma

Jun Ho Yi, Gyeong‐Won Lee, Young Rok et al. · Annals of Hematology · 2019 · 76 citations

Medicine, Oncology, Pathology +15

Dacarbazine-based chemotherapy as first-line treatment in noncutaneous metastatic melanoma

Jun Ho Yi, Seong Yoon Yi, Hyeran Lee et al. · Melanoma Research · 2011 · 72 citations

Medicine, Oncology, Pharmacotherapy +16